State Street Corp Buys 215,733 Shares of agilon health, inc. (NYSE:AGL)

State Street Corp raised its stake in shares of agilon health, inc. (NYSE:AGL) by 3.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 7,449,706 shares of the company’s stock after purchasing an additional 215,733 shares during the period. State Street Corp owned 1.81% of agilon health worth $29,277,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. AQR Capital Management LLC raised its stake in agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC lifted its stake in shares of agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after buying an additional 316,856 shares in the last quarter. Citigroup Inc. boosted its holdings in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the period. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in agilon health in the 2nd quarter worth $1,849,000. Finally, Bank of New York Mellon Corp raised its holdings in agilon health by 18.7% during the second quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock valued at $7,252,000 after acquiring an additional 174,883 shares during the period.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. TD Cowen lowered their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Sanford C. Bernstein began coverage on shares of agilon health in a research note on Wednesday, December 11th. They set a “market perform” rating and a $2.50 target price for the company. Citigroup decreased their price target on shares of agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research note on Wednesday, November 13th. Evercore ISI cut their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Finally, JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, agilon health has an average rating of “Hold” and a consensus price target of $4.28.

Insider Activity at agilon health

In other agilon health news, Director Diana Mckenzie bought 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was bought at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the transaction, the director now directly owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This trade represents a 32.20 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction on Thursday, December 5th. The shares were bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. The trade was a 27.93 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 90,000 shares of company stock valued at $198,100 in the last ninety days. Corporate insiders own 3.20% of the company’s stock.

agilon health Trading Up 4.8 %

Shares of NYSE:AGL opened at $1.97 on Friday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $811.68 million, a PE ratio of -2.10 and a beta of 0.51. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $13.28. The business’s fifty day simple moving average is $2.32 and its 200-day simple moving average is $4.25.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the previous year, the firm earned ($0.06) EPS. As a group, equities research analysts predict that agilon health, inc. will post -0.52 earnings per share for the current fiscal year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.